The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Ocular Drug Delivery Market Research Report 2025

Global Ocular Drug Delivery Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1597740

No of Pages : 91

Ask Your Query

Synopsis

The global Ocular Drug Delivery market was valued at US$ 24670 million in 2023 and is anticipated to reach US$ 35220 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need.

Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Ocular Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Drug Delivery.

Report Scope

The Ocular Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ocular Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Ocular Drug Delivery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

By Company

  • OCULAR THERAPEUTIX, INC
  • Alimera Sciences
  • Allergan, Plc
  • EyeGate Pharma
  • Valeant Pharmaceuticals International, Inc
  • Envisia Therapeutics
  • Clearside Biomedical
  • Graybug Vision Inc
  • Taiwan Liposome Company
  • Santen Pharmaceutical
  • Segment by Type
  • Ocular Insert
  • Iontophoresis
  • Intraocular Implants
  • In Situ Gel & Punctal Plugs
  • Others

Segment by Application

  • Hospitals
  • Ambulatory Surgical Centers
  • Ophthalmic Clinics
  • Homecare Settings

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ocular Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ocular Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Ocular Drug Delivery Market Overview
1.1 Product Overview and Scope of Ocular Drug Delivery
1.2 Ocular Drug Delivery Segment by Type
1.2.1 Global Ocular Drug Delivery Market Value Comparison by Type (2024-2030)
1.2.2 Ocular Insert
1.2.3 Iontophoresis
1.2.4 Intraocular Implants
1.2.5 In Situ Gel & Punctal Plugs
1.2.6 Others
1.3 Ocular Drug Delivery Segment by Application
1.3.1 Global Ocular Drug Delivery Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Ophthalmic Clinics
1.3.5 Homecare Settings
1.4 Global Ocular Drug Delivery Market Size Estimates and Forecasts
1.4.1 Global Ocular Drug Delivery Revenue 2019-2030
1.4.2 Global Ocular Drug Delivery Sales 2019-2030
1.4.3 Global Ocular Drug Delivery Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Ocular Drug Delivery Market Competition by Manufacturers
2.1 Global Ocular Drug Delivery Sales Market Share by Manufacturers (2019-2024)
2.2 Global Ocular Drug Delivery Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Ocular Drug Delivery Average Price by Manufacturers (2019-2024)
2.4 Global Ocular Drug Delivery Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ocular Drug Delivery, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ocular Drug Delivery, Product Type & Application
2.7 Ocular Drug Delivery Market Competitive Situation and Trends
2.7.1 Ocular Drug Delivery Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ocular Drug Delivery Players Market Share by Revenue
2.7.3 Global Ocular Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ocular Drug Delivery Retrospective Market Scenario by Region
3.1 Global Ocular Drug Delivery Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Ocular Drug Delivery Global Ocular Drug Delivery Sales by Region: 2019-2030
3.2.1 Global Ocular Drug Delivery Sales by Region: 2019-2024
3.2.2 Global Ocular Drug Delivery Sales by Region: 2025-2030
3.3 Global Ocular Drug Delivery Global Ocular Drug Delivery Revenue by Region: 2019-2030
3.3.1 Global Ocular Drug Delivery Revenue by Region: 2019-2024
3.3.2 Global Ocular Drug Delivery Revenue by Region: 2025-2030
3.4 North America Ocular Drug Delivery Market Facts & Figures by Country
3.4.1 North America Ocular Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Ocular Drug Delivery Sales by Country (2019-2030)
3.4.3 North America Ocular Drug Delivery Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Ocular Drug Delivery Market Facts & Figures by Country
3.5.1 Europe Ocular Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Ocular Drug Delivery Sales by Country (2019-2030)
3.5.3 Europe Ocular Drug Delivery Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ocular Drug Delivery Market Facts & Figures by Country
3.6.1 Asia Pacific Ocular Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Ocular Drug Delivery Sales by Country (2019-2030)
3.6.3 Asia Pacific Ocular Drug Delivery Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Ocular Drug Delivery Market Facts & Figures by Country
3.7.1 Latin America Ocular Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Ocular Drug Delivery Sales by Country (2019-2030)
3.7.3 Latin America Ocular Drug Delivery Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ocular Drug Delivery Market Facts & Figures by Country
3.8.1 Middle East and Africa Ocular Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Ocular Drug Delivery Sales by Country (2019-2030)
3.8.3 Middle East and Africa Ocular Drug Delivery Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Ocular Drug Delivery Sales by Type (2019-2030)
4.1.1 Global Ocular Drug Delivery Sales by Type (2019-2024)
4.1.2 Global Ocular Drug Delivery Sales by Type (2025-2030)
4.1.3 Global Ocular Drug Delivery Sales Market Share by Type (2019-2030)
4.2 Global Ocular Drug Delivery Revenue by Type (2019-2030)
4.2.1 Global Ocular Drug Delivery Revenue by Type (2019-2024)
4.2.2 Global Ocular Drug Delivery Revenue by Type (2025-2030)
4.2.3 Global Ocular Drug Delivery Revenue Market Share by Type (2019-2030)
4.3 Global Ocular Drug Delivery Price by Type (2019-2030)
5 Segment by Application
5.1 Global Ocular Drug Delivery Sales by Application (2019-2030)
5.1.1 Global Ocular Drug Delivery Sales by Application (2019-2024)
5.1.2 Global Ocular Drug Delivery Sales by Application (2025-2030)
5.1.3 Global Ocular Drug Delivery Sales Market Share by Application (2019-2030)
5.2 Global Ocular Drug Delivery Revenue by Application (2019-2030)
5.2.1 Global Ocular Drug Delivery Revenue by Application (2019-2024)
5.2.2 Global Ocular Drug Delivery Revenue by Application (2025-2030)
5.2.3 Global Ocular Drug Delivery Revenue Market Share by Application (2019-2030)
5.3 Global Ocular Drug Delivery Price by Application (2019-2030)
6 Key Companies Profiled
6.1 OCULAR THERAPEUTIX, INC
6.1.1 OCULAR THERAPEUTIX, INC Corporation Information
6.1.2 OCULAR THERAPEUTIX, INC Description and Business Overview
6.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.1.4 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Product Portfolio
6.1.5 OCULAR THERAPEUTIX, INC Recent Developments/Updates
6.2 Alimera Sciences
6.2.1 Alimera Sciences Corporation Information
6.2.2 Alimera Sciences Description and Business Overview
6.2.3 Alimera Sciences Ocular Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Alimera Sciences Ocular Drug Delivery Product Portfolio
6.2.5 Alimera Sciences Recent Developments/Updates
6.3 Allergan, Plc
6.3.1 Allergan, Plc Corporation Information
6.3.2 Allergan, Plc Description and Business Overview
6.3.3 Allergan, Plc Ocular Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Allergan, Plc Ocular Drug Delivery Product Portfolio
6.3.5 Allergan, Plc Recent Developments/Updates
6.4 EyeGate Pharma
6.4.1 EyeGate Pharma Corporation Information
6.4.2 EyeGate Pharma Description and Business Overview
6.4.3 EyeGate Pharma Ocular Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.4.4 EyeGate Pharma Ocular Drug Delivery Product Portfolio
6.4.5 EyeGate Pharma Recent Developments/Updates
6.5 Valeant Pharmaceuticals International, Inc
6.5.1 Valeant Pharmaceuticals International, Inc Corporation Information
6.5.2 Valeant Pharmaceuticals International, Inc Description and Business Overview
6.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Product Portfolio
6.5.5 Valeant Pharmaceuticals International, Inc Recent Developments/Updates
6.6 Envisia Therapeutics
6.6.1 Envisia Therapeutics Corporation Information
6.6.2 Envisia Therapeutics Description and Business Overview
6.6.3 Envisia Therapeutics Ocular Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Envisia Therapeutics Ocular Drug Delivery Product Portfolio
6.6.5 Envisia Therapeutics Recent Developments/Updates
6.7 Clearside Biomedical
6.6.1 Clearside Biomedical Corporation Information
6.6.2 Clearside Biomedical Description and Business Overview
6.6.3 Clearside Biomedical Ocular Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Clearside Biomedical Ocular Drug Delivery Product Portfolio
6.7.5 Clearside Biomedical Recent Developments/Updates
6.8 Graybug Vision Inc
6.8.1 Graybug Vision Inc Corporation Information
6.8.2 Graybug Vision Inc Description and Business Overview
6.8.3 Graybug Vision Inc Ocular Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Graybug Vision Inc Ocular Drug Delivery Product Portfolio
6.8.5 Graybug Vision Inc Recent Developments/Updates
6.9 Taiwan Liposome Company
6.9.1 Taiwan Liposome Company Corporation Information
6.9.2 Taiwan Liposome Company Description and Business Overview
6.9.3 Taiwan Liposome Company Ocular Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Taiwan Liposome Company Ocular Drug Delivery Product Portfolio
6.9.5 Taiwan Liposome Company Recent Developments/Updates
6.10 Santen Pharmaceutical
6.10.1 Santen Pharmaceutical Corporation Information
6.10.2 Santen Pharmaceutical Description and Business Overview
6.10.3 Santen Pharmaceutical Ocular Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Santen Pharmaceutical Ocular Drug Delivery Product Portfolio
6.10.5 Santen Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ocular Drug Delivery Industry Chain Analysis
7.2 Ocular Drug Delivery Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ocular Drug Delivery Production Mode & Process
7.4 Ocular Drug Delivery Sales and Marketing
7.4.1 Ocular Drug Delivery Sales Channels
7.4.2 Ocular Drug Delivery Distributors
7.5 Ocular Drug Delivery Customers
8 Ocular Drug Delivery Market Dynamics
8.1 Ocular Drug Delivery Industry Trends
8.2 Ocular Drug Delivery Market Drivers
8.3 Ocular Drug Delivery Market Challenges
8.4 Ocular Drug Delivery Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock